Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- Check3 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, reflecting a minor update to the page version.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s UI/release version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3” without changing the study details shown.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0. This change does not affect core study details or patient-facing information.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check103 days agoChange DetectedRevision updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.